Literature DB >> 16819611

Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

A Mari1, M Manco, C Guidone, G Nanni, M Castagneto, G Mingrone, E Ferrannini.   

Abstract

AIMS/HYPOTHESIS: The aim of this study was to analyse the mechanisms underlying the improvement in glucose tolerance seen in morbidly obese patients undergoing bilio-pancreatic diversion (BPD). SUBJECTS AND METHODS: We evaluated glucose tolerance (by OGTT), insulin sensitivity (euglycaemic-hyperinsulinaemic clamp and the OGTT index OGIS) and beta cell function (OGTT modelling analysis) in 32 morbidly obese (BMI=52+/-7 kg/m(2), mean+/-SD) patients (12 with NGT, 9 with IGT and 11 with type 2 diabetes), before and after BPD, and in 22 lean control subjects. Patients were studied before and from 7 days to 60 months after surgery.
RESULTS: BPD improved glucose tolerance in all subjects, who after surgery all had normal glucose tolerance. Insulin sensitivity was restored to normal levels in all subjects (pre-BPD 341+/-79 ml min(-1) m(-2), post-BPD 511+/-57 ml min(-1) m(-2), lean 478+/-49 ml min(-1) m(-2)). The insulin sensitivity change was detectable within 10 days of BPD. At baseline, beta cell sensitivity to glucose was impaired in diabetic subjects (25 [18] pmol min(-1) m(-2) l mmol(-1), median [interquartile range]) compared with lean subjects (82 [98]; p</=0.05). After BPD, beta cell glucose sensitivity showed a tendency towards improvement but remained impaired in diabetic subjects (30 [62]; p<0.01 vs lean). Total insulin output decreased in parallel with the insulin sensitivity increase in all groups. In the whole patient group, mean OGTT glucose levels were inversely related to both insulin sensitivity and beta cell glucose sensitivity (r (2)=0.67, partial r=-0.76 and -0.41, respectively). NEFAs, leptin and adiponectin were related to insulin sensitivity but could not explain the early improvement. CONCLUSIONS/
INTERPRETATION: Following BPD, glucose tolerance was restored mainly as a result of a rapid and large improvement in insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819611     DOI: 10.1007/s00125-006-0337-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.

Authors:  Andrea Mari; Ole Schmitz; Amalia Gastaldelli; Torben Oestergaard; Birgit Nyholm; Ele Ferrannini
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-08-06       Impact factor: 4.310

Review 2.  Potential of surgery for curing type 2 diabetes mellitus.

Authors:  Francesco Rubino; Michel Gagner
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure.

Authors:  S B Heymsfield; S Lichtman; R N Baumgartner; J Wang; Y Kamen; A Aliprantis; R N Pierson
Journal:  Am J Clin Nutr       Date:  1990-07       Impact factor: 7.045

4.  Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women.

Authors:  M R Letiexhe; A J Scheen; P L Gèrard; C Desaive; P J Lefèbvre
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

5.  A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.

Authors:  A Mari; G Pacini; E Murphy; B Ludvik; J J Nolan
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

6.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

7.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Authors:  Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

8.  The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Authors:  Francesco Rubino; Michel Gagner; Paolo Gentileschi; Subhash Kini; Shoji Fukuyama; John Feng; Ed Diamond
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients.

Authors:  M R Letiexhe; C Desaive; P J Lefèbvre; A J Scheen
Journal:  Int J Obes Relat Metab Disord       Date:  2004-06

10.  Glucose-induced thermogenesis in postobese women who have undergone biliopancreatic diversion.

Authors:  P A Tataranni; G Mingrone; A V Greco; P Caradonna; E Capristo; C A Raguso; A De Gaetano; R M Tacchino; M Castagneto
Journal:  Am J Clin Nutr       Date:  1994-09       Impact factor: 7.045

View more
  44 in total

Review 1.  Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors:  Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

2.  Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.

Authors:  N Irwin; P L McClean; F P M O'Harte; V A Gault; P Harriott; P R Flatt
Journal:  Diabetologia       Date:  2007-05-08       Impact factor: 10.122

Review 3.  The prevention of type 2 diabetes.

Authors:  Jill P Crandall; William C Knowler; Steven E Kahn; David Marrero; Jose C Florez; George A Bray; Steven M Haffner; Mary Hoskin; David M Nathan
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-05-20

4.  A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations.

Authors:  Nicola Scopinaro; Francesco Papadia; Giovanni Camerini; Giuseppe Marinari; Dario Civalleri; Adami Gian Franco
Journal:  Obes Surg       Date:  2008-05-08       Impact factor: 4.129

Review 5.  Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM).

Authors:  Selma B Souto; Eliana B Souto; Daniel C Braga; José L Medina
Journal:  Eur J Clin Pharmacol       Date:  2011-04-06       Impact factor: 2.953

Review 6.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  Epicardial and pericardial fat in type 2 diabetes: favourable effects of biliopancreatic diversion.

Authors:  Ana Carolina Junqueira Vasques; José Carlos Pareja; José Roberto Mattos Souza; Ademar Yamanaka; Maria da Saúde de Oliveira; Fernanda Satake Novaes; Élinton Adami Chaim; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Bruno Geloneze
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

8.  Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.

Authors:  Carsten Dirksen; Kirstine N Bojsen-Møller; Nils B Jørgensen; Siv H Jacobsen; Viggo B Kristiansen; Lars S Naver; Dorte L Hansen; Dorte Worm; Jens J Holst; Sten Madsbad
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

Review 9.  Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Authors:  Mousumi Bose; Blanca Oliván; Julio Teixeira; F Xavier Pi-Sunyer; Blandine Laferrère
Journal:  Obes Surg       Date:  2008-09-27       Impact factor: 4.129

Review 10.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.